首页> 外国专利> LACTOBACILLUS SP. HY7801 HAVING INHIBITORY EFFECT AGAINST URINARY TRACT INFECTION AND CANDIDIASIS, AND PRODUCTS CONTAINING THEREOF AS EFFECTIVE COMPONENT

LACTOBACILLUS SP. HY7801 HAVING INHIBITORY EFFECT AGAINST URINARY TRACT INFECTION AND CANDIDIASIS, AND PRODUCTS CONTAINING THEREOF AS EFFECTIVE COMPONENT

机译:乳杆菌HY7801具有抑制尿道感染和念珠菌的作用,及其所含产品为有效成分

摘要

PURPOSE: A composition containing Lactobacillus sp. HY7801 as an active ingredient is provided to suppress urinary tract infection and E.coli adhesion onto bladder epithelial cells. CONSTITUTION: Lactobacillus sp. HY7801 is capable of suppressing urinary tract infection and candida vaginitis. The Lactobacillus sp. HY7801 can suppress E.coli, Proteus vulgaris, Proteus mirabilis, Klebsiella oxytoca, Klebsiella pneumonia, Morganella morganii, Citrobacter freundii, Enterococcus fecalis, Enterobacter cloaca, Pseudomonas aeruginosa, or Acinetobacter banmanii. A pharmaceutical composition for preventing and treating urinary tract infection contains the Lactobaicllus sp. HY7801 as an active ingredient.
机译:目的:一种包含乳酸杆菌属的组合物。提供HY7801作为有效成分,可抑制尿路感染和大肠杆菌粘附在膀胱上皮细胞上。组成:乳杆菌。 HY7801具有抑制尿路感染和念珠菌性阴道炎的能力。乳杆菌HY7801可以抑制大肠杆菌,寻常变形杆菌,奇异变形杆菌,产酸克雷伯菌,肺炎克雷伯菌,摩根氏摩根氏菌,弗氏柠檬酸杆菌,费卡肠球菌,泄殖腔肠杆菌,铜绿假单胞菌或不动杆菌。用于预防和治疗尿路感染的药物组合物包含乳杆菌。 HY7801为有效成分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号